Model N and Pharmaceutical Executive to Present Webcast on Using Analytics to Drive Agile Brand Management

Share Article

Pharma Practitioners to Discuss How to Build the Capabilities that Lead to Optimal Brand Performance

Model N, the leader in Revenue Management solutions, is partnering with Pharmaceutical Executive to present “The Path to Agile Brand Management," a live webcast on October 25, 2012 at 2 p.m. EDT.

The pharmaceutical sales and marketing landscape is undergoing a significant transformation, requiring a new approach to achieving brand revenue goals. Today’s ultra-competitive environment requires speed and agility from both Sales and Marketing executives. David Stasior, M.D., Vice President and Chief Evangelist, Analytics at Model N and Jason Jones, Senior Director of Sales Operations and Insights at Covidien, will discuss key areas where a shared understanding of brand performance across Sales and Marketing can lead to agile decision making and consistent achievement of brand performance objectives.

Key Discussion Areas:

  •     Defining agile brand management and how it creates a competitive advantage
  •     Why a shared understanding across Sales and Marketing fosters agility
  •     How to enable agile brand management in a pharmaceutical company


Social Media Links

Follow Model N on Twitter
Follow Model N Linked In

About Model N

Model N, the leader in Revenue Management solutions, drives improved pricing, margin, and revenue performance through a powerful combination of best practices, highly configurable software applications, comprehensive services, and actionable analytics across the complete functional spectrum of pricing, contracting, rebating, sales, and marketing. Model N leverages its deep industry expertise to support the unique business needs of Life Sciences and High Tech manufacturers across more than 50 countries. Global Customers include: Allergan, Amgen, Atmel, Boston Scientific, Bristol-Myers Squibb, Dell, Hospira, Johnson & Johnson, Linear Technology, Merck, Marvell, Maxim, Micron, Nokia, Novartis, Novo Nordisk, ON Semiconductor, STMicroelectronics, and Watson Pharmaceuticals. Whether you are an emerging business or a global leader, Model N results in revenue.

Model N is a trademark of Model N, Inc. Any other company names mentioned are the property of their respective owners and are mentioned for identification purposes only.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sean Cassidy
Visit website